ADC Therapeutics SA (ADCT) reported Q4 EPS of ($0.10), $0.38 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $19.8 million versus the consensus estimate of $55.8 million.
ADC Therapeutics SA (ADCT) reported Q4 EPS of ($0.10), $0.38 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $19.8 million versus the consensus estimate of $55.8 million.